COAG - Company ID 0002114044
As of 2026-07-10, Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $1.74 B, making it the #2259 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-10 | $1.74 B |
| 2026-07-09 | $1.74 B |
| 2026-07-08 | $1.59 B |
| 2026-07-07 | $1.47 B |
| 2026-07-06 | $1.45 B |
| 2026-07-05 | $1.45 B |
| 2026-07-04 | $1.45 B |
| 2026-07-03 | $1.45 B |
| 2026-07-02 | $1.46 B |
| 2026-07-01 | $1.53 B |
| 2026-06-30 | $1.72 B |
| 2026-06-29 | $1.76 B |
As of 2026-07-10, Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $1.74 B, making it the #2259 most valuable US-listed company.
Hemab Therapeutics Holdings, Inc. is the #2259 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-28 | $1.51 B |
| 2026-06-27 | $1.51 B |
| 2026-06-26 | $1.36 B |
| 2026-06-25 | $1.33 B |
| 2026-06-24 | $1.36 B |
| 2026-06-23 | $1.36 B |
| 2026-06-22 | $1.40 B |
| 2026-06-21 | $1.37 B |
| 2026-06-20 | $1.37 B |
| 2026-06-19 | $1.37 B |
| 2026-06-18 | $1.33 B |
| 2026-06-17 | $1.24 B |
| 2026-06-16 | $1.19 B |
| 2026-06-15 | $1.17 B |
| 2026-06-14 | $1.17 B |
| 2026-06-13 | $1.17 B |
| 2026-06-12 | $1.21 B |
| 2026-06-11 | $1.26 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.